96 related articles for article (PubMed ID: 7488118)
1. Receptor-linked antigen delivery system. Importance of autologous alpha 2-macroglobulin in the development of peptide vaccine.
Mitsuda S; Nakagawa T; Nakazato H; Ikai A
Biochem Biophys Res Commun; 1995 Nov; 216(1):399-405. PubMed ID: 7488118
[TBL] [Abstract][Full Text] [Related]
2. A receptor mediated delivery of an HIV-1 derived peptide vaccine.
Mitsuda S; Nakagawa T; Osada T; Shimamoto T; Nakazato H; Ikai A
Biochem Biophys Res Commun; 1993 Aug; 194(3):1155-60. PubMed ID: 7688961
[TBL] [Abstract][Full Text] [Related]
3. A receptor-mediated antigen delivery and incorporation system. Administration of alpha 2-macroglobulin-cytochrome c conjugate induced high concentrations of antibodies against cytochrome c in mice.
Mitsuda S; Nakagawa T; Osada T; Ikai A
Biochem Biophys Res Commun; 1993 Mar; 191(3):1326-31. PubMed ID: 7682069
[TBL] [Abstract][Full Text] [Related]
4. Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand.
Sailaja G; Husain S; Nayak BP; Jabbar AM
J Immunol; 2003 Mar; 170(5):2496-507. PubMed ID: 12594275
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. Clin Exp Immun 1994;98:178-84.
DePalma L
Pediatr AIDS HIV Infect; 1995 Apr; 6(2):97-8. PubMed ID: 11361387
[No Abstract] [Full Text] [Related]
6. Receptor-mediated antigen delivery into macrophages. Complexing antigen to alpha 2-macroglobulin enhances presentation to T cells.
Chu CT; Pizzo SV
J Immunol; 1993 Jan; 150(1):48-58. PubMed ID: 7678035
[TBL] [Abstract][Full Text] [Related]
7. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
[TBL] [Abstract][Full Text] [Related]
8. Mapping of structure-function relationships in proteins with a panel of monoclonal antibodies. A study on human alpha 2 macroglobulin.
Van Leuven F; Marynen P; Cassiman JJ; Van den Berghe H
J Immunol Methods; 1988 Jun; 111(1):39-49. PubMed ID: 2455752
[TBL] [Abstract][Full Text] [Related]
9. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.
Morrot A; Strickland DK; Higuchi Mde L; Reis M; Pedrosa R; Scharfstein J
Int Immunol; 1997 Jun; 9(6):825-34. PubMed ID: 9199965
[TBL] [Abstract][Full Text] [Related]
10. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
Fuller DH; Haynes JR
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant-free in vivo targeting. Antigen delivery by alpha 2-macroglobulin enhances antibody formation.
Chu CT; Oury TD; Enghild JJ; Pizzo SV
J Immunol; 1994 Feb; 152(4):1538-45. PubMed ID: 7509826
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated endocytosis of alpha 2-macroglobulin: solubilization and partial purification of the fibroblast alpha 2-macroglobulin receptor.
Hanover JA; Willingham MC; Pastan I
Ann N Y Acad Sci; 1983; 421():410-23. PubMed ID: 6202215
[TBL] [Abstract][Full Text] [Related]
13. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
[TBL] [Abstract][Full Text] [Related]
14. An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice.
LaMarre J; Hayes MA; Wollenberg GK; Hussaini I; Hall SW; Gonias SL
J Clin Invest; 1991 Jan; 87(1):39-44. PubMed ID: 1702100
[TBL] [Abstract][Full Text] [Related]
15. Adjuvanticity of alpha 2-macroglobulin, an independent ligand for the heat shock protein receptor CD91.
Binder RJ; Karimeddini D; Srivastava PK
J Immunol; 2001 Apr; 166(8):4968-72. PubMed ID: 11290775
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.
Khattar SK; Palaniyandi S; Samal S; LaBranche CC; Montefiori DC; Zhu X; Samal SK
Hum Vaccin Immunother; 2015; 11(2):504-15. PubMed ID: 25695657
[TBL] [Abstract][Full Text] [Related]
17. Modulation of antigen-induced T cell proliferation by alpha 2M-trypsin complexes.
Mannhalter JW; Borth W; Eibl MM
J Immunol; 1986 Apr; 136(8):2792-9. PubMed ID: 2420868
[TBL] [Abstract][Full Text] [Related]
18. Absence of specific binding of receptor-mediated endocytosis, and of secretion of alpha-2-macroglobulin by cultured endothelial cells.
Marynen P; Van der Schueren B; Van Leuven F; Cassiman JJ; Van den Berghe H
Haemostasis; 1982; 11(4):210-4. PubMed ID: 6182057
[TBL] [Abstract][Full Text] [Related]
19. Production of long-lived neutralizing antibodies to HIV-1 IIIB in mice with a vaccinia recombinant virus-infected cell vaccine expressing gp160.
Parry C; McLain L; Dimmock NJ
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):205-12. PubMed ID: 8198873
[TBL] [Abstract][Full Text] [Related]
20. Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.
Kovacs JA; Vasudevachari MB; Easter M; Davey RT; Falloon J; Polis MA; Metcalf JA; Salzman N; Baseler M; Smith GE
J Clin Invest; 1993 Aug; 92(2):919-28. PubMed ID: 7688766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
